Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wendtner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Radiology|May 25, 2001
Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humansA Baur, A Huber, S Arbogast, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermiaC Wendtner, S Abdel-Rahman, J Baumert, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II studyR D Issels, S Abdel-Rahman, C Wendtner, et al.
ESMO Open|March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert ConsensusC Buske, M Dreyling, A Alvarez-Larrán, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Radiology|May 25, 2001
Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humansA Baur, A Huber, S Arbogast, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermiaC Wendtner, S Abdel-Rahman, J Baumert, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2001
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II studyR D Issels, S Abdel-Rahman, C Wendtner, et al.
ESMO Open|March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert ConsensusC Buske, M Dreyling, A Alvarez-Larrán, et al.
Pageof 1